Biolase Inc (BIOL):企業の財務・戦略的SWOT分析

◆英語タイトル:Biolase Inc (BIOL) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C4969
◆発行会社(調査会社):GlobalData
◆発行日:2018年9月
◆ページ数:50
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Biolase Inc (BIOL) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Biolase Inc (Biolase) develops, manufactures, markets and sells dental lasers and related products. It also distributes dental imaging equipment, including cone beam digital x-rays and CAD/CAM intra-oral scanners. The company offers two categories of laser systems: WaterLase systems and Diode systems. Its laser systems find applications in minimally invasive dental procedures, such as cosmetic, restorative and complex surgical applications. Biolase offers these products to dentists, periodontists, endodontists, oral surgeons and other dental specialists. It also offers consumables products, other imaging system products and maintenance service. The company distributes its products through direct sales force, agents and distributors. It has operations in the Americas, Europe, the Middle East and Asia-Pacific. Biolase is headquartered in California, the US.

Biolase Inc Key Recent Developments

Aug 08,2018: BIOLASE names Todd A. Norbe President, Chief Executive Officer
Jun 19,2018: BIOLASE Names Todd A. Norbe And Jess Roper As Board Directors
May 09,2018: BIOLASE and Los Angeles Chargers Partner to Bring Advanced Dental Care to Children in Underserved Communities in Southern California
May 02,2018: BIOLASE Announces 2018 First Quarter Results
Apr 11,2018: BIOLASE Board Of Directors Asks Chairman Jonathan T. Lord, M.D. To Take On Expanded Leadership Role And Explore Strategic Options

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Section 1 – About the Company 6
Biolase Inc – Key Facts 6
Biolase Inc – Key Employees 7
Biolase Inc – Key Employee Biographies 8
Biolase Inc – Major Products and Services 9
Biolase Inc – History 10
Biolase Inc – Company Statement 14
Biolase Inc – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Section 2 – Company Analysis 17
Company Overview 17
Biolase Inc – Business Description 18
Business Segment: Consumables and other 18
Overview 18
Performance 18
Business Segment: Imaging systems 18
Overview 18
Performance 18
Business Segment: Laser Systems 18
Overview 18
Performance 19
Key Stats 19
Business Segment: License fees and royalties 19
Overview 19
Performance 19
Business Segment: Services 19
Overview 19
Performance 19
Geographical Segment: International 19
Performance 19
Geographical Segment: United States 19
Performance 19
Biolase Inc – Corporate Strategy 20
Biolase Inc – SWOT Analysis 21
SWOT Analysis – Overview 21
Biolase Inc – Strengths 21
Biolase Inc – Weaknesses 22
Biolase Inc – Opportunities 23
Biolase Inc – Threats 24
Biolase Inc – Key Competitors 25
Section 3 – Company Financial Ratios 26
Financial Ratios – Capital Market Ratios 26
Financial Ratios – Annual Ratios 27
Performance Chart 29
Financial Performance 29
Financial Ratios – Interim Ratios 30
Financial Ratios – Ratio Charts 31
Section 4 – Company’s Lifesciences Financial Deals and Alliances 32
Biolase Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 32
Biolase Inc, Medical Equipment, Deals By Type, 2012 to YTD 2018 33
Biolase Inc, Recent Deals Summary 34
Section 5 – Company’s Recent Developments 35
Aug 08, 2018: BIOLASE names Todd A. Norbe President, Chief Executive Officer 35
Jun 19, 2018: BIOLASE Names Todd A. Norbe And Jess Roper As Board Directors 36
May 09, 2018: BIOLASE and Los Angeles Chargers Partner to Bring Advanced Dental Care to Children in Underserved Communities in Southern California 37
May 02, 2018: BIOLASE Announces 2018 First Quarter Results 38
Apr 11, 2018: BIOLASE Board Of Directors Asks Chairman Jonathan T. Lord, M.D. To Take On Expanded Leadership Role And Explore Strategic Options 40
Apr 04, 2018: BIOLASE Names Garrett Sato To Board Of Directors 41
Mar 28, 2018: BIOLASE Announces Growing Awareness of Dental Lasers Among Pediatric Dentists, Demonstrating Shift Toward Pain-Free Dentistry 42
Mar 07, 2018: BIOLASE Secures $6 Million Revolving Line Of Credit 43
Feb 15, 2018: BIOLASE Announces Initiatives to Increase Dental Laser Awareness and Education in Southern California 44
Jan 25, 2018: BIOLASE Rejects Frivolous, Abusive Patent Litigation 45
Section 6 – Appendix 46
Methodology 46
Ratio Definitions 46
About GlobalData 50
Contact Us 50
Disclaimer 50

List of Tables
Biolase Inc, Key Facts 6
Biolase Inc, Key Employees 7
Biolase Inc, Key Employee Biographies 8
Biolase Inc, Major Products and Services 9
Biolase Inc, History 10
Biolase Inc, Subsidiaries 16
Biolase Inc, Key Competitors 25
Biolase Inc, Ratios based on current share price 26
Biolase Inc, Annual Ratios 27
Biolase Inc, Annual Ratios (Cont...1) 28
Biolase Inc, Interim Ratios 30
Biolase Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 32
Biolase Inc, Medical Equipment, Deals By Type, 2012 to YTD 2018 33
Biolase Inc, Recent Deals Summary 34
Currency Codes 46
Capital Market Ratios 46
Equity Ratios 47
Profitability Ratios 47
Cost Ratios 48
Liquidity Ratios 48
Leverage Ratios 49
Efficiency Ratios 49

List of Figures
Biolase Inc, Performance Chart (2013 - 2017) 29
Biolase Inc, Ratio Charts 31
Biolase Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 32
Biolase Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 33

★海外企業調査レポート[Biolase Inc (BIOL):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Ignyta Inc:医療機器:M&Aディール及び事業提携情報
    Summary Ignyta Inc (Ignyta), formerly NexDx Inc, a subsidiary of F. Hoffmann-La Roche Ltd, is a cancer care service provider. The company discovers, develops and commercializes new drugs targeting activated genes in cancer cells. It develops products using integrated therapeutic technology (Rx/Dx). …
  • TSO3 Inc (TOS):企業の財務・戦略的SWOT分析
    TSO3 Inc (TOS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Empresa Nacional del Petroleo:電力:M&Aディール及び事業提携情報
    Summary Empresa Nacional del Petroleo (ENAP) is a state-owned integrated oil and gas company. It carries out exploration, development and production of hydrocarbons. The company has major upstream operations in Magallanes region of Chile. ENAP also carries out refining, transportation, storage, and …
  • Tandem Diabetes Care Inc (TNDM):医療機器:M&Aディール及び事業提携情報
    Summary Tandem Diabetes Care Inc (Tandem) is a medical device company that designs, develops and manufactures diabetic care products. The company provides products such as t:slim X2 insulin pump, t:slim G4 insulin pump, t:flex insulin pump, t:simulator demo app, software and apps, t:connect applicat …
  • Mercuria Energy Group Ltd:企業の戦略的SWOT分析
    Mercuria Energy Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Harvard Bioscience Inc (HBIO):製薬・医療:M&Aディール及び事業提携情報
    Summary Harvard Bioscience Inc (Harvard Bioscience) develops, manufactures and markets scientific instruments systems and lab consumables. The company’s product portfolio encompasses physiology, cell, molecular instruments products; electrophysiology products; and laboratory products and supplies. I …
  • Otter Tail Corp (OTTR):企業の財務・戦略的SWOT分析
    Otter Tail Corp (OTTR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Noile-Immune Biotech Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Noile-Immune Biotech Inc (Noile-Immune Biotech) is a clinical stage biotechnology company that develops and commercializes next generation CAR-T cell therapies for the treatment of cancer. The company works in collaboration with National Cancer Center Japan and Yamaguchi University to develo …
  • Mithra Pharmaceuticals SA (MITRA):企業の財務・戦略的SWOT分析
    Summary Mithra Pharmaceuticals SA (Mithra) is a developer and manufacturer of over the counter products and prescription drugs for women’s health and other applications. The company offers products such as estelle, donesta, tibelia, zoreline and myring, among others. Its products are used in the tre …
  • AvStar Aviation Services Inc:企業の戦略的SWOT分析
    AvStar Aviation Services Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Experian PLC (EXPN):企業の財務・戦略的SWOT分析
    Experian PLC (EXPN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Seacor Holdings Inc (CKH):石油・ガス:M&Aディール及び事業提携情報
    Summary Seacor Holdings Inc (Seacor) is a diversified holding company that offers domestic and international transportation and logistics and risk management consultancy services. The company operates through business segments such as ocean transportation and logistics services, inland transportatio …
  • Tufts Medical Center-医療機器分野:企業M&A・提携分析
    Summary Tufts Medical Center (TMC), formerly New England Medical Center Hospital Inc, a subsidiary of Tufts University School of Medicine, is an academic medical center that provides patient care services. The center offers treatments for brain tumor, breast cancer, cardiac arrhythmia, cardiomyopath …
  • 10X Genomics, Inc.:製薬・医療:M&Aディール及び事業提携情報
    Summary 10X Genomics, Inc. (10X Genomics) is engaged in developing an innovative genomics platform. The company’s product pipeline comprises of chromium controller, single cell ATAC sequencer and single cell with barcode technology. It offers single cell gene expression, single cell immune profiling …
  • Adenovir Pharma AB-製薬・医療分野:企業M&A・提携分析
    Summary Adenovir Pharma AB (Adenovir Pharma) is a drug development company that develops antiviral medicinal solutions for the treatment of infectious diseases such as adenoviral conjunctivitis and epidemic keratoconjunctivitis affecting the eyes. The company’s products are eye drops which acts outs …
  • Universal Display Corp (OLED):企業の財務・戦略的SWOT分析
    Summary Universal Display Corp (UDC) is a clean technology company that conducts research, develops and markets organic light emitting diode, technologies and materials. The company offers PHOLED materials which are used in making OLED displays and lighting panels. It provides technologies such as F …
  • Indra Sistemas, S.A.:企業の戦略・SWOT・財務分析
    Indra Sistemas, S.A. - Strategy, SWOT and Corporate Finance Report Summary Indra Sistemas, S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • University College London:企業のM&A・事業提携・投資動向
    University College London - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's University College London Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • PT Bank Danamon Indonesia Tbk (BDMN):企業の財務・戦略的SWOT分析
    PT Bank Danamon Indonesia Tbk (BDMN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • GateHouse Media, Inc.:企業のM&A・事業提携・投資動向
    GateHouse Media, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's GateHouse Media, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆